Cholera Vaccination Campaign Amid Ongoing Outbreak

By Crystal Lubbe

January 15, 2025

The cholera vaccination campaign in South Sudan has been initiated in Rubkona County as part of efforts to address and control the ongoing cholera outbreak. This campaign aims to provide protection to over 300,000 vulnerable individuals in Rubkona County, which is recognised as a hotspot area facing severe cholera challenges.

Cholera Outbreak and Vaccination Campaign

The cholera vaccination campaign in South Sudan focuses on combating the ongoing cholera outbreak in Rubkona County, Unity State, as part of broader health initiatives to contain the spread of this disease.

Target Population

Authorities are targeting more than 300,000 people in Rubkona County for vaccination, highlighting the urgent need in one of the region’s areas most severely affected by cholera.

Partners and Support

Several international partners are lending their support to this vital vaccination campaign, including the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), and Médecins Sans Frontières (MSF).

Government Commitment

The commitment from South Sudan’s government, particularly from the Ministry of Health and the Vice President for Service Cluster, is crucial in the fight against the cholera outbreak through different measures, notably vaccination campaigns.

Comprehensive Prevention and Response Strategy

The initiative includes oral cholera vaccine campaigns, improved surveillance, patient care, risk communication, and sustainable WASH interventions.

Challenges and Context

Humanitarian crises, poor access to safe drinking water, and inadequate sanitation services worsen the cholera outbreaks in South Sudan. Logistical challenges, including flooding and insecurity, complicate vaccination efforts.

Long-term Goals

The vaccination campaign aims to protect vulnerable groups, especially children and women. Therefore, paving the way for a healthier and more resilient future through sustainable health strategies.

The campaign highlights the collaboration between the South Sudanese government and international health organisations to manage the cholera outbreak. Protecting vulnerable populations and addressing public health challenges remain critical in these efforts.

Reference url

Recent Posts

EMA’s mCombriax Vaccine Recommendation

By HEOR Staff Writer

March 3, 2026

EMA's mCombriax Vaccine Recommendation Ushers in Dual Protection Era The mCombriax vaccine recommendation from the European Medicines Agency (EMA) marks a milestone for individuals aged 50 and older. EMA has recomm...
HERNEXEOS Lung Cancer Treatment: First FDA Approval for HER2-Mutant NSCLC

By HEOR Staff Writer

March 2, 2026

FDA Greenlights HERNEXEOS Lung Cancer Treatment as First-Line Option HERNEXEOS lung cancer treatment (zongertinib tablets), developed by
KEYTRUDA Padcev MIBC Survival: New Era in Treatment Revealed by KEYNOTE-B15 Trial Results
KEYTRUDA Padcev MIBC Survival Breakthrough in Cisplatin-Eligible Patients KEYTRUDA Padcev MIBC Survival benefits shone in the Phase 3 KEYNOTE-B15 trial, where perioperative KEYTRUDA (pembrolizumab) plus Padce...